Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-09-066093
Filing Date
2009-11-25
Accepted
2009-11-25 13:56:33
Documents
7
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a54399e10vk.htm 10-K 958944
2 EX-21.1 a54399exv21w1.htm EX-21.1 3028
3 EX-23.1 a54399exv23w1.htm EX-23.1 1510
4 EX-31.1 a54399exv31w1.htm EX-31.1 8273
5 EX-31.2 a54399exv31w2.htm EX-31.2 8585
6 EX-32.1 a54399exv32w1.htm EX-32.1 2489
7 EX-32.2 a54399exv32w2.htm EX-32.2 2534
  Complete submission text file 0000950123-09-066093.txt   986992
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

EIN.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-15803 | Film No.: 091207745
SIC: 2834 Pharmaceutical Preparations